DE3887585D1 - (Aryl oder heteroaromatische methyl)-2,2'-Bi-1H-Imidazole. - Google Patents

(Aryl oder heteroaromatische methyl)-2,2'-Bi-1H-Imidazole.

Info

Publication number
DE3887585D1
DE3887585D1 DE88111954T DE3887585T DE3887585D1 DE 3887585 D1 DE3887585 D1 DE 3887585D1 DE 88111954 T DE88111954 T DE 88111954T DE 3887585 T DE3887585 T DE 3887585T DE 3887585 D1 DE3887585 D1 DE 3887585D1
Authority
DE
Germany
Prior art keywords
aryl
imidazoles
substituted
heteroaromatic methyl
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88111954T
Other languages
English (en)
Other versions
DE3887585T2 (de
Inventor
Donald P Matthews
James R Mccarthy
Jeffrey P Whitten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE3887585D1 publication Critical patent/DE3887585D1/de
Publication of DE3887585T2 publication Critical patent/DE3887585T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
DE3887585T 1987-07-28 1988-07-25 (Aryl oder heteroaromatische methyl)-2,2'-Bi-1H-Imidazole. Expired - Fee Related DE3887585T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/078,352 US4839375A (en) 1987-07-28 1987-07-28 (Aryl or heteroaromatic methyl)-2,2'-bi-1H-imidazoles and their use as anti-hypertensive agents

Publications (2)

Publication Number Publication Date
DE3887585D1 true DE3887585D1 (de) 1994-03-17
DE3887585T2 DE3887585T2 (de) 1994-05-26

Family

ID=22143494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3887585T Expired - Fee Related DE3887585T2 (de) 1987-07-28 1988-07-25 (Aryl oder heteroaromatische methyl)-2,2'-Bi-1H-Imidazole.

Country Status (19)

Country Link
US (1) US4839375A (de)
EP (1) EP0301456B1 (de)
JP (1) JP2750578B2 (de)
KR (1) KR970011301B1 (de)
CN (1) CN1016173B (de)
AT (1) ATE101151T1 (de)
AU (1) AU605609B2 (de)
CA (1) CA1338786C (de)
DE (1) DE3887585T2 (de)
DK (1) DK420588A (de)
ES (1) ES2063008T3 (de)
FI (1) FI883499A (de)
HU (1) HU202861B (de)
IL (1) IL87217A (de)
NO (1) NO169841C (de)
NZ (1) NZ225561A (de)
PH (1) PH26551A (de)
PT (1) PT88121B (de)
ZA (1) ZA885360B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69931837T2 (de) * 1998-03-20 2006-11-09 China Petrochemical Corp. Hydroentschwefelung von Kohlenwasserstoffölen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670563A (en) * 1984-06-20 1987-06-02 Sanofi Imidazolides as intermediates for the synthesis of cytotoxic conjugates
PH22526A (en) * 1985-11-25 1988-10-17 Merrell Dow Pharma 2-2' bi-ih-imidazoles
JP2581556B2 (ja) * 1986-05-06 1997-02-12 メレルダウファーマスーティカルズ インコーポレーテッド 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤

Also Published As

Publication number Publication date
CN1034718A (zh) 1989-08-16
FI883499A0 (fi) 1988-07-25
NO169841B (no) 1992-05-04
PT88121B (pt) 1995-03-01
AU605609B2 (en) 1991-01-17
EP0301456B1 (de) 1994-02-02
NZ225561A (en) 1990-12-21
NO169841C (no) 1992-08-12
AU1976588A (en) 1989-02-02
DK420588A (da) 1989-01-29
DE3887585T2 (de) 1994-05-26
JPS6440465A (en) 1989-02-10
KR890002112A (ko) 1989-04-08
KR970011301B1 (ko) 1997-07-09
NO883322D0 (no) 1988-07-27
EP0301456A2 (de) 1989-02-01
NO883322L (no) 1989-01-30
US4839375A (en) 1989-06-13
ZA885360B (en) 1989-03-29
DK420588D0 (da) 1988-07-27
EP0301456A3 (en) 1990-12-05
ATE101151T1 (de) 1994-02-15
PT88121A (pt) 1989-07-31
CN1016173B (zh) 1992-04-08
IL87217A0 (en) 1988-12-30
HUT53900A (en) 1990-12-28
JP2750578B2 (ja) 1998-05-13
CA1338786C (en) 1996-12-10
HU202861B (en) 1991-04-29
IL87217A (en) 1992-07-15
PH26551A (en) 1992-08-19
FI883499A (fi) 1989-01-29
ES2063008T3 (es) 1995-01-01

Similar Documents

Publication Publication Date Title
ES8607969A1 (es) Un procedimiento para preparar un derivado de acido quinoli-no naftiridin- carboxilico
ATE21105T1 (de) 7-oxo-4-thia-1-aza(3.2.0)heptan- und 7-oxo-4-thia-1-aza-(3.2.0)hept-2-en-derivate.
IT7928377A0 (it) Procedimento per la produzione dicombustibile ottenuto dall'essicamento per polverizzazione di fanghi.
DK543787D0 (da) Antibakterielle midler
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
DE3764724D1 (de) 2-phenylbenzoxepin-derivat.
DE69122866D1 (de) Herstellung von substituierten piperidinen
FI895185A0 (fi) Mevalonolaktoner av tienopyridintyp.
PT87277A (pt) Process for the preparation of new bicyclic compounds and pharmaceutical compositions comprising same
ES545195A0 (es) Un procedimiento para preparar derivados de purina
IT8420358A0 (it) Procedimento di preparazione di derivati 1-carbamoilmetilici di 4-idrossi-2-osso-pirrolidina nonche' di intermedi per ottenere tali composti.
DE3887585D1 (de) (Aryl oder heteroaromatische methyl)-2,2'-Bi-1H-Imidazole.
ATE58532T1 (de) (2-amino-4-aryl-thiazol-5-yl)aethanol, und deren derivate mit diuretischer aktivitaet und verfahren zu deren herstellung.
FR2567514B1 (fr) Nouveaux ether-oxydes derives de cyclopropylphenols
NO904135D0 (no) Fremgangsmaate for fremstilling av nye alkylpiperidiner.
ES2044900T3 (es) Un proceso para la preparacion de un derivado de antraciclina.
ES2046528T3 (es) Derivados heterotetraciclicos de lactamas, proceso para su preparacion y composiciones farmaceuticas a base de los mismos.
ES2033256T3 (es) Procedimiento para preparar derivados fluorados de la vitamina d3.
ATE125261T1 (de) 2-tetrahydrofuran-enantiomerderivate, zwischenprodukte davon und ihre herstellung.
ES535795A0 (es) Un procedimiento para preparar nuevas 5-aminometil-imidazol-1-il-1,3-dialquil-1h-pirazol-4-il-aroil-metanonas
KR850006405A (ko) 메플로킨 항말라리아 화합물의 키닌산염

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee